Author: Cassidy Mentus; Martin Romeo; Christian DiPaola
Title: Analysis and Applications of Non-Adaptive and Adaptive Group Testing Methods for COVID-19 Document date: 2020_4_7
ID: 3sr4djft_103
Snippet: In the current phase of the pandemic, testing for the presence of COVID-19 targeted antibodies using viral antigens such as the ELISA assay are being used to test for both exposure and immunity. It is an important topic to explore how antibody tests can be most eectively used in tandem with PCR tests leading to the largest possible testing capacity. Antibody tests are important especially to discover whether rst responders are potentially exposed.....
Document: In the current phase of the pandemic, testing for the presence of COVID-19 targeted antibodies using viral antigens such as the ELISA assay are being used to test for both exposure and immunity. It is an important topic to explore how antibody tests can be most eectively used in tandem with PCR tests leading to the largest possible testing capacity. Antibody tests are important especially to discover whether rst responders are potentially exposed and immune to the disease. As antibody tests are not yet produced enabling point of care usage, there is a scarcity of antibody testing capacity just as there is PCR testing capacity. Is it feasible to apply group testing methods to antibody assays?
Search related documents:
Co phrase search for related documents- antibody assay and immunity exposure: 1, 2, 3
- antibody assay and PCR test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- antibody assay and PCR testing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- antibody assay and target antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- antibody assay and viral antigen: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- antibody test and ELISA assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58
- antibody test and immunity exposure: 1, 2
- antibody test and PCR test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- antibody test and PCR testing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45
- antibody test and potentially expose: 1
- antibody test and target antibody: 1, 2, 3, 4, 5
- antibody test and testing capacity: 1, 2, 3, 4
- antibody test and testing method: 1, 2, 3, 4, 5
- antibody test and viral antigen: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- antibody test and viral antigen target antibody: 1
- antibody testing and ELISA assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36
- antibody testing and immunity exposure: 1, 2, 3
- antibody testing and PCR test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61
- antibody testing and PCR testing: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
Co phrase search for related documents, hyperlinks ordered by date